financetom
Business
financetom
/
Business
/
Mission Produce Fiscal Q1 Adjusted Earnings Unchanged, Revenue Declines
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mission Produce Fiscal Q1 Adjusted Earnings Unchanged, Revenue Declines
Mar 12, 2026 1:42 PM

04:26 PM EDT, 03/12/2026 (MT Newswires) -- Mission Produce ( AVO ) reported fiscal Q1 adjusted earnings late Thursday of $0.10 per diluted share, unchanged from a year earlier.

Three analysts polled by FactSet expected $0.07.

Revenue for the three months ended Jan. 31 was $278.6 million, down from $334.2 million a year earlier.

Three analysts surveyed by FactSet expected $260.7 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US natural gas pipeline Mountain Valley prepares for start-up
US natural gas pipeline Mountain Valley prepares for start-up
Jun 12, 2024
June 12 (Reuters) - U.S. natural gas pipeline venture Mountain Valley Pipeline said on Wednesday it was preparing the $7.85-billion pipe from West Virginia to Virginia to operate, after receiving approval from a U.S. energy regulator. The Mountain Valley project, the biggest gas pipeline currently under construction in the Northeast, has encountered numerous regulatory and court fights that have stopped...
Blackline Insider Bought Shares Worth $348,226, According to a Recent SEC Filing
Blackline Insider Bought Shares Worth $348,226, According to a Recent SEC Filing
Jun 12, 2024
04:21 PM EDT, 06/12/2024 (MT Newswires) -- Owen Ryan, Director, Co-CEO, on June 11, 2024, executed a purchase for 7,552 shares in Blackline ( BL ) for $348,226. Following the Form 4 filing with the SEC, Ryan has control over a total of 153,500 shares of the company, with 153,500 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1666134/000112760224018456/xslF345X03/form4.xml Price: 46.65, Change: +0.59,...
Dave & Buster's Stock Falls On Worse-Than-Expected Q1 Results: The Details
Dave & Buster's Stock Falls On Worse-Than-Expected Q1 Results: The Details
Jun 12, 2024
Dave & Buster’s Entertainment Inc. shares are falling after the company reported its first-quarter financial results Wednesday. Here's a look at the key figures from the report.  The Details: Dave & Buster’s reported quarterly earnings of $1.12 per share which missed the analyst consensus estimate of $1.70 by 34.12% and represented a 22.76% decrease from earnings of $1.45 per share...
Cara Therapeutics Discontinues NP Program After Drug Study Fails to Show Clinical Benefit -- Shares Drop
Cara Therapeutics Discontinues NP Program After Drug Study Fails to Show Clinical Benefit -- Shares Drop
Jun 12, 2024
04:23 PM EDT, 06/12/2024 (MT Newswires) -- Cara Therapeutics ( CARA ) said late Wednesday the results of a trial assessing the efficacy and safety of oral difelikefalin to treat notalgia paresthetica, a nerve disorder, didn't demonstrate meaningful clinical benefit compared to placebo. The company has decided to discontinue its clinical program in notalgia paresthetica. We will be winding down...
Copyright 2023-2026 - www.financetom.com All Rights Reserved